Drugs / Lactobacilli GR-1 and RC-14
last change Sep 2007 re-read 3 minutes ago

Lactobacilli GR-1 and RC-14

Other / unclassified

Developed for
bacterial vaginosis
Investigated by
Canadian Institutes of Health Research (CIHR) · Mount Sinai Hospital, Canada

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00217308 Feb 2005 → Jul 2007 bacterial vaginosis Mount Sinai Hospital, Canada Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lactobacilli GR-1 and RC-14 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00217308 ↗
Modality Other / unclassified “Probiotic Lactobacilli will be compared to placebo” NCT00217308 ↗